Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Roche Diagnostics Corp. is moving closer to realizing its vision of personalized health care through partnerships and applying machine learning and data sourcing. See what Rod Cotton, Roche Diagnostics' senior VP of commercial operations, said about it here.
While Medtronic PLC's Brain Therapies business was by far the fastest-growing unit in the first quarter of fiscal 2020, sales of spine surgery products grew faster in the first quarter than they have in nine quarters. See what Medtronic's CEO Omar Ishrak said about it here.
The largest diagnostics companies, including Roche Diagnostics Corp., showcased their latest products at the recent American Association for Clinical Chemistry's (AACC) conference in Anaheim. See what David Smith, regional business manager for Roche's Navify decision-support portfolio, said about it here.
Medtronic and the nonprofit health plan Capital District Physicians' Health Plan Inc. (CDPHP) announced they'll be collaborating on an outcomes-based agreement for diabetes patients using Medtronic's insulin pumps. See what Suzanne Winter, VP of Medtronic's Diabetes Group said about it here.
AtriCure Inc. has closed a $300m structured deal to acquire SentreHEART Inc., the privately held developer of the Lariat percutaneous left atrial appendage (LAA) closure device. See what AtriCure CEO Michael Carrel said about it here.
Over the past few years, the US FDA has been pulling enforcement punches, relying more on holding face-to-face regulatory meetings than firing off warning letters. See what FDA Compliance Branch director Melissa Michurski said about the meetings here.
Here's what Amy Abernethy, the second-highest ranking official at the US FDA, thinks about the use of wearable devices to collect accurate patient data for clinical trials and remote monitoring.
Long-delayed changes to the US FDA's approach to postmarketing safety reporting for combination products are set to come into effect in 2020, following the agency’s recent release of a final guidance document on the issue. See what Combination Products Coalition general counsel Bradley Merrill Thompson said about the guidance here.
Product liability lawsuits involving breast implants made by Johnson & Johnson's unit Mentor Worldwide have been dismissed by a California federal judge. See what Judge Andre Birotte Jr. said about it here.
At this year's AACC conference, Medtech Insight caught up with Siemens Healthineers' president of laboratory diagnostics Deepak Nath. See what Healthineers' Nath said about plans for their flagship Atellica solution here.
A lawsuit attempting to change how lab test fees can be determined under Medicare recently got the go-ahead from the US Court of Appeals. The suit was filed by trade group the American Clinical Laboratory Association. See what ACLA president Julie Khani said about it here.
US FDA investigator and national device expert Phil Pontikos says he's concerned about the large number of medical device recalls because of troubles with sterilization activities. Check out his comments here.
UK-based liquid biopsy company Angle PLC is expecting to make a landmark regulatory submission to the US Food and Drug Administration early in the fourth quarter of 2019 for Parsortix, which aims to detect and capture circulating tumor cells in cancer patients. See what Angle's CEO, Andrew Newland, said about it here.
In the second quarter of 2019, Stryker reported a 6% growth in sales of orthopedic devices, led by the Mako robotic surgery platform. See what Katherine Owen, Stryker's VP of strategy and investor relations, said about it here.
The latest salvo to improve kidney care in the US is a recent executive order from the Trump administration, with one of the key goals being to raise the percentage of dialysis patients on home dialysis to 80% by 2025 from 12% today. See what John Milad, CEO of UK-based Quanta Dialysis Technologies, said about it here.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.